• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一篇关于生物黏附颊部给药系统的综述:制剂和评价方法的现状。

A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods.

机构信息

Hetero Labs Ltd, IDA, Jeedimetla, Hyderabad, Andhra Pradesh ; National Facilities in Engineering and Technology with Industrial Collaboration (NAFETIC) Centre, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, India.

出版信息

Daru. 2011;19(6):385-403.

PMID:23008684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3436075/
Abstract

Owing to the ease of the administration, the oral cavity is an attractive site for the delivery of drugs. Through this route it is possible to realize mucosal (local effect) and transmucosal (systemic effect) drug administration. In the first case, the aim is to achieve a site-specific release of the drug on the mucosa, whereas the second case involves drug absorption through the mucosal barrier to reach the systemic circulation. The main obstacles that drugs meet when administered via the buccal route derive from the limited absorption area and the barrier properties of the mucosa. The effective physiological removal mechanisms of the oral cavity that take the formulation away from the absorption site are the other obstacles that have to be considered. The strategies studied to overcome such obstacles include the employment of new materials that, possibly, combine mucoadhesive, enzyme inhibitory and penetration enhancer properties and the design of innovative drug delivery systems which, besides improving patient compliance, favor a more intimate contact of the drug with the absorption mucosa. This presents a brief description of advantages and limitations of buccal drug delivery and the anatomical structure of oral mucosa, mechanisms of drug permeation followed by current formulation design in line with developments in buccal delivery systems and methodology in evaluating buccal formulations.

摘要

由于给药方便,口腔是药物投递的一个有吸引力的部位。通过该途径,可以实现粘膜(局部作用)和粘膜下(全身作用)给药。在前一种情况下,目的是实现药物在粘膜上的特定部位释放,而后一种情况则涉及通过粘膜屏障吸收药物以达到全身循环。药物经颊给药时遇到的主要障碍源于有限的吸收面积和粘膜的屏障特性。口腔有效的生理清除机制将制剂从吸收部位带走,这也是需要考虑的另一个障碍。为了克服这些障碍,研究人员采用了新的材料,这些材料可能具有粘膜黏附、酶抑制和渗透增强特性,并设计了创新的药物输送系统,除了提高患者顺应性外,还可以促进药物与吸收粘膜更紧密地接触。本文简要描述了颊部给药的优点和局限性以及口腔粘膜的解剖结构、药物渗透机制,接着介绍了与颊部给药系统发展相适应的制剂设计和评估颊部制剂的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a4/3436075/036a3b827dcb/DARU-19-385-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a4/3436075/3eac8b047011/DARU-19-385-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a4/3436075/1448ba79249b/DARU-19-385-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a4/3436075/3e943b9d1b88/DARU-19-385-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a4/3436075/036a3b827dcb/DARU-19-385-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a4/3436075/3eac8b047011/DARU-19-385-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a4/3436075/1448ba79249b/DARU-19-385-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a4/3436075/3e943b9d1b88/DARU-19-385-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a4/3436075/036a3b827dcb/DARU-19-385-g004.jpg

相似文献

1
A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods.一篇关于生物黏附颊部给药系统的综述:制剂和评价方法的现状。
Daru. 2011;19(6):385-403.
2
Buccal drug delivery: A challenge already won?口腔给药:已然攻克的挑战?
Drug Discov Today Technol. 2005 Spring;2(1):59-65. doi: 10.1016/j.ddtec.2005.05.018.
3
Chemical permeation enhancers for transbuccal drug delivery.经口腔黏膜给药的化学渗透增强剂。
Expert Opin Drug Deliv. 2010 Jan;7(1):97-112. doi: 10.1517/17425240903338758.
4
Drug delivery from the oral cavity: a focus on mucoadhesive buccal drug delivery systems.口腔给药:聚焦于黏膜黏附性口腔药物递送系统。
PDA J Pharm Sci Technol. 2012 Sep-Oct;66(5):466-500. doi: 10.5731/pdajpst.2012.00877.
5
An overview of polymeric dosage forms in buccal drug delivery: State of art, design of formulations and their in vivo performance evaluation.聚合物口腔给药剂型概述:现状、制剂设计及其体内性能评价。
Mater Sci Eng C Mater Biol Appl. 2018 May 1;86:129-143. doi: 10.1016/j.msec.2017.12.022. Epub 2017 Dec 21.
6
Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.口腔生物黏附给药——口服效率较低药物的一个有前景的选择。
J Control Release. 2006 Aug 10;114(1):15-40. doi: 10.1016/j.jconrel.2006.04.012. Epub 2006 Jul 7.
7
An Updated Overview of the Emerging Role of Patch and Film-Based Buccal Delivery Systems.基于贴片和薄膜的口腔给药系统新出现作用的最新综述
Pharmaceutics. 2021 Aug 5;13(8):1206. doi: 10.3390/pharmaceutics13081206.
8
The use of mucoadhesive polymers in buccal drug delivery.粘膜粘附聚合物在口腔给药中的应用。
Adv Drug Deliv Rev. 2005 Nov 3;57(11):1666-91. doi: 10.1016/j.addr.2005.07.003. Epub 2005 Sep 23.
9
Critical evaluation of permeation enhancers for oral mucosal drug delivery.口腔黏膜给药促渗剂的评价。
Drug Dev Ind Pharm. 2010 Mar;36(3):254-82. doi: 10.1080/03639040903117348.
10
Novel strategies for the buccal delivery of macromolecules.大分子经颊部给药的新策略。
Drug Dev Ind Pharm. 2014 May;40(5):579-90. doi: 10.3109/03639045.2014.892960. Epub 2014 Mar 10.

引用本文的文献

1
Development of Vancomycin, a Glycopeptide Antibiotic, in a Suitable Nanoform for Oral Delivery.万古霉素(一种糖肽类抗生素)适用于口服给药的纳米制剂的研发。
Molecules. 2025 Apr 5;30(7):1624. doi: 10.3390/molecules30071624.
2
In vitro and ex vivo models of the oral mucosa as platforms for the validation of novel drug delivery systems.作为新型药物递送系统验证平台的口腔黏膜体外和离体模型。
J Tissue Eng. 2025 Feb 11;16:20417314241313458. doi: 10.1177/20417314241313458. eCollection 2025 Jan-Dec.
3
Various topical drug combination assessed using a neurosensory stent for chronic intraoral neuropathic pain: a pilot study.

本文引用的文献

1
Buccal drug delivery: A challenge already won?口腔给药:已然攻克的挑战?
Drug Discov Today Technol. 2005 Spring;2(1):59-65. doi: 10.1016/j.ddtec.2005.05.018.
2
In vivo bioavailability studies of sumatriptan succinate buccal tablets.舒马曲坦琥珀酸盐口腔贴片的体内生物利用度研究。
Daru. 2011;19(3):224-30.
3
Development of bioadhesive buccal tablets for felodipine and pioglitazone in combined dosage form: in vitro, ex vivo, and in vivo characterization.开发用于非洛地平/吡格列酮联合制剂的生物粘附颊片剂:体外、离体和体内特性研究。
使用神经感觉支架评估多种局部药物组合治疗慢性口腔内神经性疼痛的初步研究。
J Oral Facial Pain Headache. 2024 Sep;38(3):38-45. doi: 10.22514/jofph.2024.025. Epub 2024 Sep 12.
4
Buccal Absorption of Biopharmaceutics Classification System III Drugs: Formulation Approaches and Mechanistic Insights.生物药剂学分类系统III类药物的口腔吸收:制剂方法与机制见解
Pharmaceutics. 2024 Dec 6;16(12):1563. doi: 10.3390/pharmaceutics16121563.
5
Nanotechnology in Drug Delivery: Anatomy and Molecular Insight into the Self-Assembly of Peptide-Based Hydrogels.药物递送中的纳米技术:基于肽的水凝胶自组装的剖析与分子洞察
Molecules. 2024 Nov 29;29(23):5654. doi: 10.3390/molecules29235654.
6
Efficacy and Safety of Fluconazole Mucoadhesive Patches in Human Immunodeficiency Virus-Related Oral Candidiasis.氟康唑粘膜粘附贴片治疗人类免疫缺陷病毒相关口腔念珠菌病的疗效与安全性
J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241299014. doi: 10.1177/23259582241299014.
7
Implementing the Design of Experiments (DoE) Concept into the Development of Mucoadhesive Tablets Containing Orange Peel Extract as a Potential Concept for the Treatment of Oral Infections.将实验设计(DoE)概念应用于含橙皮提取物的黏膜黏附片的开发,作为治疗口腔感染的潜在概念。
Materials (Basel). 2024 Oct 28;17(21):5234. doi: 10.3390/ma17215234.
8
Impact of Thermo-Responsive N-Acetylcysteine Hydrogel on Dermal Wound Healing and Oral Ulcer Regeneration.温度响应性 N-乙酰半胱氨酸水凝胶对皮肤创伤愈合和口腔溃疡再生的影响。
Int J Mol Sci. 2024 Apr 29;25(9):4835. doi: 10.3390/ijms25094835.
9
Natural and Synthetic Drugs Approached for the Treatment of Recurrent Aphthous Stomatitis Over the Last Decade.近十年用于治疗复发性阿弗他口炎的天然和合成药物。
Drug Des Devel Ther. 2024 Apr 22;18:1297-1312. doi: 10.2147/DDDT.S449370. eCollection 2024.
10
Pullulan-Based Spray-Dried Mucoadhesive Microparticles for Sustained Oromucosal Drug Delivery.基于普鲁兰多糖的喷雾干燥粘膜粘附性微粒用于口腔粘膜药物的持续递送
Pharmaceutics. 2024 Mar 26;16(4):460. doi: 10.3390/pharmaceutics16040460.
Drug Deliv. 2011 Jul;18(5):344-52. doi: 10.3109/10717544.2011.557786. Epub 2011 Feb 25.
4
Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: in vitro and ex vivo characterization.环糊精包合在用于口腔黏膜给药的非洛地平持续释放基质片中的作用:体外和离体特性研究。
Pharm Dev Technol. 2012 May-Jun;17(3):321-32. doi: 10.3109/10837450.2010.535829. Epub 2011 Jan 26.
5
Poloxamer 407 microspheres for orotransmucosal drug delivery. Part II: In vitro/in vivo evaluation.泊洛沙姆 407 微球用于口腔黏黏膜给药。第二部分:体外/体内评价。
Int J Pharm. 2010 Nov 15;400(1-2):32-6. doi: 10.1016/j.ijpharm.2010.08.018. Epub 2010 Aug 20.
6
Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies.用于口腔黏膜局部递药的纳米颗粒:原理验证研究。
Pharm Res. 2010 Jul;27(7):1224-36. doi: 10.1007/s11095-010-0121-y. Epub 2010 Mar 31.
7
Development of novel bioadhesive buccal formulation of diltiazem: in vitro and in vivo characterization.新型地尔硫卓生物粘附性口腔制剂的研发:体外和体内特性研究
PDA J Pharm Sci Technol. 2009 Sep-Oct;63(5):401-8.
8
Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers.猪颊黏膜作为体外模型:上皮组织和结缔组织作为渗透屏障的相对作用
J Pharm Sci. 2009 Feb;98(2):471-83. doi: 10.1002/jps.21436.
9
Transbuccal delivery of chlorpheniramine maleate from mucoadhesive buccal patches.马来酸氯苯那敏经黏膜黏附性口腔贴片的口腔给药
Drug Deliv. 2008 Mar-Apr;15(3):185-91. doi: 10.1080/10717540801952639.
10
Pharmaceutical applications of hot-melt extrusion: part I.热熔挤出的药物应用:第一部分。
Drug Dev Ind Pharm. 2007 Sep;33(9):909-26. doi: 10.1080/03639040701498759.